Cargando…

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study

BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millgate, Edward, Kravariti, Eugenia, Egerton, Alice, Howes, Oliver D, Murray, Robin M, Kassoumeri, Laura, Donocik, Jacek, Lewis, Shôn, Drake, Richard, Lawrie, Stephen, Murphy, Anna, Collier, Tracy, Lees, Jane, Stockton-Powdrell, Charlotte, Walters, James, Deakin, Bill, MacCabe, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Mental Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627394/ https://www.ncbi.nlm.nih.gov/pubmed/34824121 http://dx.doi.org/10.1136/bmjopen-2021-054160

Ejemplares similares

Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
por: Millgate, Edward, et al.
Publicado: (2022)

Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
por: Griffiths, Kira, et al.
Publicado: (2022)

Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
por: Egerton, Alice, et al.
Publicado: (2022)

Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
por: Egerton, Alice, et al.
Publicado: (2020)

Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
por: Millgate, Edward, et al.
Publicado: (2022)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

Peripheral immune markers and antipsychotic non-response in psychosis
por: Enache, Daniela, et al.
Publicado: (2021)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
por: Gillespie, Amy L., et al.
Publicado: (2017)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium
por: Smart, Sophie E., et al.
Publicado: (2022)

Biological Predictors of Clozapine Response: A Systematic Review
por: Samanaite, Ruta, et al.
Publicado: (2018)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia
por: McCutcheon, R., et al.
Publicado: (2017)

Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study
por: Millgate, Edward, et al.
Publicado: (2023)

Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities
por: Jones, Brett D M, et al.
Publicado: (2021)

Long-term responses to treatment in UK veterans with military-related PTSD: an observational study
por: Murphy, Dominic, et al.
Publicado: (2016)

Depression, depressive symptoms and treatments in women who have recently given birth: UK cohort study
por: Petersen, Irene, et al.
Publicado: (2018)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

Digital screening for postnatal depression: mixed methods proof-of-concept study
por: Eisner, Emily, et al.
Publicado: (2022)

O3.7. EFFECT OF N-ACETYLCYSTEINE ON BRAIN GLUTAMATE LEVELS AND RESTING PERFUSION IN SCHIZOPHRENIA
por: McQueen, Grant, et al.
Publicado: (2018)

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
por: Pillinger, Toby, et al.
Publicado: (2019)

Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies
por: Cumming, Craig, et al.
Publicado: (2022)

Vulnerable Strata to Non-Adherence and Overuse in Treatment for Patients with Cognitive Impairment
por: Moon, Yeonsil, et al.
Publicado: (2020)

Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
por: Jin, Huajie, et al.
Publicado: (2019)

Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review
por: Gabriel, Franciele Cordeiro, et al.
Publicado: (2022)

Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2018)

Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study
por: Jauhar, Sameer, et al.
Publicado: (2018)

How have predictors, moderators, mediators, treatment response, remission and resistance been defined and measured in randomised controlled trials for adolescent depression? A scoping review protocol
por: Courtney, Darren, et al.
Publicado: (2020)

Subjective experiences of cognitive decline and receiving a diagnosis of dementia: qualitative interviews with people recently diagnosed in memory clinics in the UK
por: Xanthopoulou, Penny, et al.
Publicado: (2019)

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis
por: Furukawa, Toshi A, et al.
Publicado: (2016)

Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2019)

Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
por: Krajner, Fanni, et al.
Publicado: (2022)

Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
por: Legge, Sophie E., et al.
Publicado: (2016)

Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND)
por: Morriss, Richard, et al.
Publicado: (2020)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Use of novel psychoactive substances by inpatients on general adult psychiatric wards
por: Stanley, Jack L, et al.
Publicado: (2016)

Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions
por: Bennett, Kyle H, et al.
Publicado: (2017)

Topological Strata of Weighted Complex Networks
por: Petri, Giovanni, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nlqc33uarmqfgq9sl94ucgq2t9